A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus

Clinical trial NCT02111096 · TERMINATED

Trial details

NCT number: NCT02111096
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2014-04-01
Primary completion: 2015-09-01
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.